MedTrace Logo

MCI: CPAP Treatment of OSA (Memories2)

NCT03113461 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 327

Last updated 2023-04-12

No results posted yet for this study

Summary

The purpose of this project is to determine whether obstructive sleep apnea (OSA) treatment with positive airway pressure therapy (CPAP) can delay the progression of cognitive impairment in patients with amnestic Mild Cognitive Impairment (MCI) as measured by cognitive testing, and brain magnetic resonance imaging (MRI) scans. Study participants will be assessed at baseline, six-month (cognitive tests only) and one-year follow-up.

Conditions

Interventions

DEVICE

CPAP

non-invasive positive airway pressure applied using an oronasal mask

Sponsors & Collaborators

Principal Investigators

  • Nalaka Gooneratne, MD, MSc · Associate Professor

  • Kathy Richards, PhD · Professor

  • David Wolk, MD · Associate Professor

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-19
Primary Completion
2023-01-31
Completion
2025-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03113461 on ClinicalTrials.gov